{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T02:04:06Z","timestamp":1776909846316,"version":"3.51.2"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"the International Agency for Research on Cancer, partially supported by European Commission FP7 Marie Curie Actions, People, Co-funding of regional, national, and international programmes (COFUND)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13643-017-0510-y","type":"journal-article","created":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T10:54:31Z","timestamp":1498647271000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["What determines the effects and costs of breast cancer screening? A protocol of a systematic review of reviews"],"prefix":"10.1186","volume":"6","author":[{"given":"O.","family":"Mandrik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. I.","family":"Ekwunife","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Zielonke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Meheus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L.","family":"Severens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. K.","family":"Lhachimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Murillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,28]]},"reference":[{"key":"510_CR1","volume-title":"Women\u2019s health. Fact sheet no. 334","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. Women\u2019s health. Fact sheet no. 334. 2013. http:\/\/www.who.int\/mediacentre\/factsheets\/fs334\/en\/ . Accessed 21 Oct 2015."},{"issue":"Suppl 5","key":"510_CR2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/annonc\/mdv298","volume":"26","author":"E Senkus","year":"2015","unstructured":"Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E, Zackrisson S, Cardoso F. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26 Suppl 5:8\u201330.","journal-title":"Ann Oncol"},{"key":"510_CR3","unstructured":"U.S. Preventive Service Task Force: breast cancer: screening. January 2016. https:\/\/www.uspreventiveservicestaskforce.org\/Page\/Document\/UpdateSummaryFinal\/breast-cancer-screening1?ds=1&s=mammography%20screening . Accessed 10 Jan 2017."},{"issue":"24","key":"510_CR4","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1056\/NEJMsr1504363","volume":"372","author":"B Lauby-Secretan","year":"2015","unstructured":"Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, Straif K. International Agency for Research on Cancer Handbook Working Group. Breast-cancer screening\u2014viewpoint of the IARC Working Group. N Engl J Med. 2015;372(24):2353\u20138.","journal-title":"N Engl J Med"},{"issue":"15","key":"510_CR5","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1001\/jama.2015.12783","volume":"314","author":"KC Oeffinger","year":"2015","unstructured":"Oeffinger KC, Fontham ET, Etzioni R, Herzig A. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 2015;314(15):1599\u2013614.","journal-title":"JAMA"},{"key":"510_CR6","unstructured":"Breast screening: programme overview. 1 June 2015. https:\/\/www.gov.uk\/guidance\/breast-screeningprogramme-overview. Accessed 16 June 2017."},{"key":"510_CR7","doi-asserted-by":"crossref","unstructured":"Drummond M, Barbieri M, Cook J, Glick HA, Lis J, Malik F, Reed SD, Rutten F, Sculpher M, Severens J. Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report. Value Health. 2009;12(4):409\u201318.","DOI":"10.1111\/j.1524-4733.2008.00489.x"},{"issue":"7","key":"510_CR8","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/cas.12693","volume":"106","author":"C Hamashima","year":"2015","unstructured":"Hamashima C, Ohta K, Kasahara Y, Katayama T, Nakayama T, Honjo S, Ohnuki K. A meta-analysis of mammographic screening with and without clinical breast examination. Cancer Sci. 2015;106(7):812\u20138.","journal-title":"Cancer Sci"},{"issue":"5","key":"510_CR9","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5124\/jkma.2015.58.5.408","volume":"58","author":"EH Lee","year":"2015","unstructured":"Lee EH, Park B, Kim NS, Seo HJ, Ko KL, Min JW, Shin MH, Lee K, Lee S, Choi N, Hur MH, Kim D, Kim MJ, Kim SY, Sunwoo S, Dang JY, Kim SY, Kim Y, Lee WC, Jeong J. The Korean guideline for breast cancer screening. J Korean Med Assoc. 2015;58(5):408\u201319.","journal-title":"J Korean Med Assoc"},{"key":"510_CR10","volume-title":"Screening for breast cancer: a systematic review to update the 2009 U.S. Preventive Services Task Force recommendation","author":"HD Nelson","year":"2016","unstructured":"Nelson HD, Cantor A, Humphrey L, Fu R, Pappas M, Daeges M, Griffin J. Screening for breast cancer: a systematic review to update the 2009 U.S. Preventive Services Task Force recommendation. Rockville: Agency for Healthcare Research and Quality (US); 2016. Report No.: 14-05201-EF-1."},{"key":"510_CR11","first-page":"CD001877","volume":"6","author":"PC G\u00f8tzsche","year":"2013","unstructured":"G\u00f8tzsche PC, J\u00f8rgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2013;6:CD001877.","journal-title":"Cochrane Database Syst Rev"},{"key":"510_CR12","volume-title":"Cochrane handbook for systematic reviews of interventions version 5.1.0.","year":"2011","unstructured":"Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0. 2011. The Cochrane Collaboration; www.handbook.cochrane.org . Accessed 10 Jan 2017."},{"key":"510_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA, PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.","journal-title":"Syst Rev"},{"key":"510_CR14","unstructured":"PROSPERO. International prospective register of systematic reviews. National Institute for Health Research. https:\/\/www.crd.york.ac.uk\/PROSPERO\/ . Accessed 10 Jan 2017."},{"key":"510_CR15","unstructured":"American Society of Clinical oncology: research and progress. https:\/\/www.asco.org\/ . Accessed 10 Jan 2017."},{"key":"510_CR16","unstructured":"American Cancer Society: explore the research. http:\/\/www.cancer.org\/ . Accessed 10 Jan 2017."},{"key":"510_CR17","unstructured":"The International Agency for Research on Cancer: publications. https:\/\/www.iarc.fr\/ . Accessed 10 Jan 2017."},{"key":"510_CR18","unstructured":"The European Society for Medical Oncology: science and education on OncologyPro.\/ http:\/\/www.esmo.org\/ . Accessed 10 Jan 2017."},{"key":"510_CR19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2288-7-10","volume":"7","author":"BJ Shea","year":"2007","unstructured":"Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, Porter AC, Tugwell P, Moher D, Bouter LM. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007;7:10.","journal-title":"BMC Med Res Methodol"},{"key":"510_CR20","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. BMJ. 2009;339:b2535.","journal-title":"BMJ"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-017-0510-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T06:44:00Z","timestamp":1569566640000},"score":1,"resource":{"primary":{"URL":"http:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-017-0510-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,28]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["510"],"URL":"https:\/\/doi.org\/10.1186\/s13643-017-0510-y","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,28]]},"article-number":"122"}}